Neomycin(NM) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Neomycin(NM) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-19-1 | 1. BSA-Neomycin(NM) 2. Anti-Neomycin(NM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-19-2 | 1. OVA-Neomycin(NM) 2. Anti-Neomycin(NM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-19-3 | 1. BSA-Neomycin(NM) 2. Anti-Neomycin(NM) human monoclonal antibody | $2709.00 |
GMP-SMT-19-4 | 1. OVA-Neomycin(NM) 2. Anti-Neomycin(NM) human monoclonal antibody | $2709.00 |
GMP-SMT-19-Ag-1 | BSA-Neomycin(NM) | $756.00 |
GMP-SMT-19-Ag-2 | OVA-Neomycin(NM) | $756.00 |
GMP-SMT-19-Ab-1 | Anti-Neomycin(NM) mouse monoclonal antibody | $1953.00 |
GMP-SMT-19-Ab-2 | Anti-Neomycin(NM) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Neomycin(NM)
Cat No. | GMP-SMT-19-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Neomycin(NM) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Neomycin(NM) had been validated with our anti-Hapten antibody Anti-Neomycin(NM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Neomycin(NM)
Cat No. | GMP-SMT-19-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Neomycin(NM) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Neomycin(NM) had been validated with our anti-Hapten antibody Anti-Neomycin(NM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Neomycin(NM) mouse monoclonal antibody
Cat No. | GMP-SMT-19-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.50 |
Products description | The anti-Hapten antibody against hapten Neomycin(NM) had been validated with our hapten hapten-carrier conjugates BSA-Neomycin(NM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Neomycin(NM) human monoclonal antibody
Cat No. | GMP-SMT-19-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.50 |
Products description | The anti-Hapten antibody against hapten Neomycin(NM) had been validated with our hapten hapten-carrier conjugates BSA-Neomycin(NM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Neomycin (NM) in Veterinary Drug Residues and Additives:
Neomycin, also known as NM, is a member of the aminoglycoside class of antibiotics. This small molecule has a pivotal role within the domain of veterinary drug residues and additives, and its significance cannot be overstated. In veterinary medicine, Neomycin serves as a vital tool for managing and preventing bacterial infections in animals. It is frequently administered to address a spectrum of conditions, including respiratory, gastrointestinal, and urinary tract infections in both livestock and companion animals.
In the context of veterinary drug residues, Neomycin assumes significant importance in ensuring the integrity of the food supply chain. The use of antibiotics like Neomycin in animal feed can result in the presence of residual traces in animal products, encompassing meat, milk, and eggs. Rigorous monitoring and control of Neomycin residues are imperative, aligning with stringent regulatory directives and, more importantly, safeguarding human health.
2. The Significance of Measuring Neomycin (NM):
1.Residue Surveillance: Accurate measurement of Neomycin levels is essential due to the potential presence of residues in animal-derived products. This analytical endeavor ensures the continued safety and wholesomeness of food products destined for human consumption.
2.Regulatory Adherence: Neomycin is subject to regulatory oversight, with established maximum residue limits (MRLs) in various animal products. Precise measurement is a critical step in ensuring compliance with these prescribed limits, mitigating legal liabilities.
3.Safety and Quality Assurance: The quantification of Neomycin is indispensable to maintain the safety and quality of food products. This systematic approach safeguards the end consumer against potential health hazards associated with antibiotic residues.
4.Optimizing Animal Feed: When Neomycin functions as an additive in animal feed, accurate measurement is imperative to control the dosage effectively, facilitating optimal growth promotion and disease prevention in animal populations.
3. Veterinary Drug Residues and Public Health:
The presence of antibiotic residues in animal-derived food products poses a significant concern to public health. Improperly managed antibiotic use in veterinary medicine can lead to residues exceeding safe levels, which, when consumed by humans, may contribute to the development of antibiotic resistance. The overuse and misuse of antibiotics, such as Neomycin, in animal agriculture can lead to antibiotic-resistant strains of bacteria, making it challenging to treat infections in both animals and humans. This phenomenon necessitates rigorous monitoring and measurement of antibiotic residues, such as Neomycin, in animal products.
4. Regulatory Framework and Maximum Residue Limits:
To address these concerns, regulatory agencies worldwide have established maximum residue limits (MRLs) for antibiotics like Neomycin in animal-derived products. These limits are designed to ensure that the levels of antibiotic residues in food products are safe for human consumption. Precise measurement and adherence to these MRLs are critical to avoid violations, legal repercussions, and potential health risks.
5. Neomycin as an Animal Feed Additive:
Neomycin also plays a pivotal role as an additive in animal feed formulations. Its inclusion has been observed to enhance animal growth rates and elevate feed efficiency, making it an indispensable component in contemporary animal husbandry practices. The precise measurement of Neomycin in animal feed is essential to ensure that the dosage is accurate, balancing the need for growth promotion and disease prevention while avoiding excessive residues in animal products.
6. Analytical Techniques for Measuring Neomycin:
The accurate measurement of Neomycin in veterinary drug residues and additives relies on advanced analytical techniques. High-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) are commonly employed methods. These techniques allow for the sensitive and specific quantification of Neomycin, ensuring that residues are within safe limits and that animal feed formulations contain the appropriate levels for effective disease prevention and growth promotion.
7. Conclusion:
In summary, Neomycin (NM) plays a pivotal role in veterinary medicine and animal husbandry, both as an antibiotic for treating bacterial infections and as an additive in animal feed to promote growth and disease prevention. Precise measurement of Neomycin is vital to ensure regulatory compliance, the safety of food products, and the effectiveness of Neomycin in animal feed. This comprehensive approach safeguards both animal and human health by mitigating antibiotic resistance risks and ensuring the integrity of the food supply chain. Veterinary drug residues and additives, including Neomycin, require continued vigilance and scientific measurement to uphold public health and food safety standards.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.